Pfizer tests new Drug's safety in first human trial
NCT ID NCT06712082
Summary
This early-stage study aimed to check the safety and how the body processes a single dose of an experimental medicine called PF-07264660 in healthy Chinese adults. Twelve participants received either the medicine or a placebo (inactive substance) through an IV drip and were monitored for about six months. The main goal was to see how the drug behaves in the body and identify any side effects, not to treat a disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huashan Hospital,Fudan University
Shanghai, Shanghai Municipality, 200040, China
-
Huashan Hospital,Fudan University
Shanghai, Shanghai Municipality, 201107, China
Conditions
Explore the condition pages connected to this study.